Related Experiment Video
Updated: Aug 11, 2025

A Biomimetic Model for Liver Cancer to Study Tumor-Stroma Interactions in a 3D Environment with Tunable Bio-Physical Properties
Published on: August 7, 2020
Fueling HCC Dynamics: Interplay Between Tumor Microenvironment and Tumor Initiating Cells
Hongyang Huang1, Yu-Man Tsui1, Irene Oi-Lin Ng1
1Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong; State Key Laboratory of Liver Research, The University of Hong Kong, Hong Kong.
Liver tumor-initiating cells (LTICs) drive aggressive liver cancer through plasticity and interaction with the tumor microenvironment (TME). Targeting LTICs and the TME offers new therapeutic strategies for hepatocellular carcinoma.
Area of Science:
- Oncology
- Cancer Biology
- Immunology
Background:
- Hepatocellular carcinoma (HCC) is an aggressive cancer with poor prognosis, characterized by high rates of relapse, metastasis, and chemoresistance.
- Liver tumor-initiating cells (LTICs) are a critical subpopulation within HCC tumors, responsible for tumor heterogeneity, recurrence, metastasis, and drug resistance.
- The tumor microenvironment (TME) plays a crucial role in nurturing LTICs, creating an immunosuppressive niche that promotes tumor progression.
Purpose of the Study:
- To review the plasticity of LTICs, including cellular differentiation, epithelial-mesenchymal transition, and metabolic reprogramming.
- To examine the components of the TME and their role in supporting LTIC functions.
- To explore the intricate interactions between LTICs and the TME, highlighting molecular mechanisms and therapeutic implications.
Main Methods:
- Literature review of current research on liver cancer, LTICs, and the TME.
- Analysis of molecular signaling pathways involved in LTIC plasticity and TME modulation.
- Synthesis of findings to identify novel therapeutic targets and strategies.
Main Results:
- LTIC plasticity, encompassing differentiation, EMT, and metabolic changes, is a key driver of HCC aggressiveness.
- The TME provides essential support for LTICs through both cellular and non-cellular components, fostering an immunosuppressive environment.
- Complex interactions between LTICs and the TME are mediated by various molecular mechanisms, influencing tumorigenesis and progression.
Conclusions:
- Understanding LTIC plasticity and TME dynamics is crucial for developing effective liver cancer therapies.
- Targeting LTICs and modulating the TME, particularly through immunotherapy, presents promising avenues for improving patient outcomes in HCC.
- Novel therapeutic strategies should focus on disrupting the symbiotic relationship between LTICs and their microenvironment.
Related Concept Videos
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

